1. P1353: EFFICACY OF SARSCOV2 VACCINATION IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION. A MULTICENTER EXPERIENCE. (23rd June 2022) Authors: Stirparo, L.; Autore, F.; Innocenti, I.; Papa, E.; Marchesi, F.; Togni, C.; Mariani, S.; Torrieri, L.; Salvatori, M.; Fazio, F.; Metafuni, E.; Giammarco, S.; Sorà, F.; Falcucci, P.; Ferrari, A.; Trisolini, S. M.; Tafuri, A.; Chiusolo, P.; Sica, S.; Laurenti, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL. (12th June 2019) Authors: Tiacci, E.; De Carolis, L.; Simonetti, E.; Zaja, F.; Capponi, M.; Ambrosetti, A.; Lucia, E.; Antolino, A.; Pulsoni, A.; Ferrari, S.; Zinzani, P.; Rigacci, L.; Gaidano, G.; Della Seta, R.; Frattarelli, N.; Falcucci, P.; Visani, G.; Foà, R.; Falini, B. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗